Caisse de Depot et Placement du Quebec (CDPQ)
NBIX icon

Caisse de Depot et Placement du Quebec (CDPQ)’s Neurocrine Biosciences NBIX Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91M Buy
539,961
+446,339
+477% +$66.2M 0.13% 177
2026
Q1 		$12.3M Buy
93,622
+30,709
+49% +$4.07M 0.02% 414
2025
Q4 		$8.92M Buy
+62,913
New +$9.11M 0.02% 422
2025
Q2 		– Sell
-399,648
Closed -$44.2M – 575
2025
Q1 		$44.2M Sell
399,648
-348,711
-47% -$44.2M 0.09% 218
2024
Q4 		$102M Buy
748,359
+11,449
+2% +$1.42M 0.21% 112
2024
Q3 		$84.9M Buy
736,910
+80,792
+12% +$11.1M 0.17% 144
2024
Q2 		$90.3M Buy
656,118
+504,435
+333% +$69.2M 0.22% 113
2024
Q1 		$20.9M Buy
151,683
+76,938
+103% +$10.5M 0.05% 250
2023
Q4 		$9.85M Buy
74,745
+14,156
+23% +$1.63M 0.03% 295
2023
Q3 		$6.82M Sell
60,589
-108,080
-64% -$11.4M 0.02% 311
2023
Q2 		$15.9M Sell
168,669
-173,763
-51% -$17M 0.04% 267
2023
Q1 		$34.7M Buy
342,432
+298,056
+672% +$31M 0.1% 192
2022
Q4 		$5.3M Buy
44,376
+21,500
+94% +$2.52M 0.02% 395
2022
Q3 		$2.43M Buy
22,876
+20,623
+915% +$2.09M 0.01% 424
2022
Q2 		$220K Sell
2,253
-22,516
-91% -$2.08M ﹤0.01% 573
2022
Q1 		$2.32M Buy
24,769
+6,800
+38% +$576K 0.01% 494
2021
Q4 		$1.53M Sell
17,969
-1,300
-7% -$120K ﹤0.01% 472
2021
Q3 		$1.85M Buy
19,269
+4,000
+26% +$378K ﹤0.01% 447
2021
Q2 		$1.49M Buy
+15,269
New +$1.46M ﹤0.01% 431

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s NBIX Position: Q2 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) increased its Neurocrine Biosciences (NBIX) stake by 477% in Q2 2026, buying an estimated $66.2M and bringing the position to 539,961 shares worth $91M. The position accounts for 0.13% of the portfolio, ranked #177.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in NBIX in Q2 2021 and has held it in 19 quarters since. The position peaked at $102M in Q4 2024. 775 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Caisse de Depot et Placement du Quebec (CDPQ) held 539,961 shares of Neurocrine Biosciences worth $91M as of Q2 2026.
  • Caisse de Depot et Placement du Quebec (CDPQ) bought 446,339 Neurocrine Biosciences shares in Q2 2026, an estimated $66.2M.
  • Neurocrine Biosciences made up 0.13% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q2 2026, its #177 holding.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Neurocrine Biosciences in Q2 2021 and has held it in 19 quarters since.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Neurocrine Biosciences position peaked at $102M in Q4 2024.
  • 775 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.